Cardiac and Multiorgan Transplantation for End-Stage Congenital Heart Disease
Abstract Objective To report our single-center experience with patients who had cardiac and multiorgan transplantation for end-stage congenital heart disease (CHD). Patients and Methods We reviewed records for all patients with CHD who had undergone heart transplantation at Mayo Clinic, Rochester, M...
Saved in:
Published in | Mayo Clinic proceedings Vol. 89; no. 4; pp. 478 - 483 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Inc
01.04.2014
Elsevier, Inc Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract Objective To report our single-center experience with patients who had cardiac and multiorgan transplantation for end-stage congenital heart disease (CHD). Patients and Methods We reviewed records for all patients with CHD who had undergone heart transplantation at Mayo Clinic, Rochester, Minnesota, from November 1, 1990, through June 30, 2012. Patients with cardiomyopathy were excluded, unless CHD was present. Results Overall, 45 patients had cardiac transplantation for end-stage CHD (mean age, 26.1±18.4 years; range, 1 month to 65 years). Two patients (4%) had combined heart/liver transplantation; 1 (2%) had heart/kidney transplantation. Six patients (13%) had no previous cardiac operation; the remaining 39 patients had a mean of 3 (range, 1-8) previous cardiac operations. Patient survival (95% CI) at 1, 5, and 10 years was 89% (80%-98%), 89% (80%-98%), and 72% (56%-87%), respectively, while graft survival at 1, 5, and 10 years was 89% (80%-98%), 89% (80%-98%), and 61% (44%-78%), respectively. During the same era, the International Society for Heart & Lung Transplantation reported that survival in patients undergoing transplant for non-congenital diagnoses was 85%, 72%, and 56%, respectively. Over a mean follow-up of 8.7±6.2 years, rejection requiring treatment was documented in 35 patients (78%). Eleven patients (24%) have been diagnosed with neoplasia (8 skin, 1 blood, 1 lymph, and 1 other), and 3 patients (7%) have required retransplantation. Four patients (9%) have developed significant coronary vasculopathy; 1 successfully underwent retransplantation, and 3 died 6, 8, and 14 years after transplantation. Conclusion With appropriate patient selection and posttransplant monitoring, survival has improved for patients with complex end-stage CHD. Multiorgan transplantation is an option for selected patients with CHD. |
---|---|
AbstractList | To report our single-center experience with patients who had cardiac and multiorgan transplantation for end-stage congenital heart disease (CHD). We reviewed records for all patients with CHD who had undergone heart transplantation at Mayo Clinic, Rochester, Minnesota, from November 1, 1990, through June 30, 2012. Patients with cardiomyopathy were excluded, unless CHD was present. Overall, 45 patients had cardiac transplantation for end-stage CHD (mean age, 26.1±18.4 years; range, 1 month to 65 years). Two patients (4%) had combined heart/liver transplantation; 1 (2%) had heart/kidney transplantation. Six patients (13%) had no previous cardiac operation; the remaining 39 patients had a mean of 3 (range, 1-8) previous cardiac operations. Patient survival (95% CI) at 1, 5, and 10 years was 89% (80%-98%), 89% (80%-98%), and 72% (56%-87%), respectively, while graft survival at 1, 5, and 10 years was 89% (80%-98%), 89% (80%-98%), and 61% (44%-78%), respectively. During the same era, the International Society for Heart & Lung Transplantation reported that survival in patients undergoing transplant for non-congenital diagnoses was 85%, 72%, and 56%, respectively. Over a mean follow-up of 8.7±6.2 years, rejection requiring treatment was documented in 35 patients (78%). Eleven patients (24%) have been diagnosed with neoplasia (8 skin, 1 blood, 1 lymph, and 1 other), and 3 patients (7%) have required retransplantation. Four patients (9%) have developed significant coronary vasculopathy; 1 successfully underwent retransplantation, and 3 died 6, 8, and 14 years after transplantation. With appropriate patient selection and posttransplant monitoring, survival has improved for patients with complex end-stage CHD. Multiorgan transplantation is an option for selected patients with CHD. Abstract Objective To report our single-center experience with patients who had cardiac and multiorgan transplantation for end-stage congenital heart disease (CHD). Patients and Methods We reviewed records for all patients with CHD who had undergone heart transplantation at Mayo Clinic, Rochester, Minnesota, from November 1, 1990, through June 30, 2012. Patients with cardiomyopathy were excluded, unless CHD was present. Results Overall, 45 patients had cardiac transplantation for end-stage CHD (mean age, 26.1±18.4 years; range, 1 month to 65 years). Two patients (4%) had combined heart/liver transplantation; 1 (2%) had heart/kidney transplantation. Six patients (13%) had no previous cardiac operation; the remaining 39 patients had a mean of 3 (range, 1-8) previous cardiac operations. Patient survival (95% CI) at 1, 5, and 10 years was 89% (80%-98%), 89% (80%-98%), and 72% (56%-87%), respectively, while graft survival at 1, 5, and 10 years was 89% (80%-98%), 89% (80%-98%), and 61% (44%-78%), respectively. During the same era, the International Society for Heart & Lung Transplantation reported that survival in patients undergoing transplant for non-congenital diagnoses was 85%, 72%, and 56%, respectively. Over a mean follow-up of 8.7±6.2 years, rejection requiring treatment was documented in 35 patients (78%). Eleven patients (24%) have been diagnosed with neoplasia (8 skin, 1 blood, 1 lymph, and 1 other), and 3 patients (7%) have required retransplantation. Four patients (9%) have developed significant coronary vasculopathy; 1 successfully underwent retransplantation, and 3 died 6, 8, and 14 years after transplantation. Conclusion With appropriate patient selection and posttransplant monitoring, survival has improved for patients with complex end-stage CHD. Multiorgan transplantation is an option for selected patients with CHD. To report our single-center experience with patients who had cardiac and multiorgan transplantation for end-stage congenital heart disease (CHD). We reviewed records for all patients with CHD who had undergone heart transplantation at Mayo Clinic, Rochester, Minnesota, from November 1, 1990, through June 30, 2012. Patients with cardiomyopathy were excluded, unless CHD was present. Overall, 45 patients had cardiac transplantation for end-stage CHD (mean age, 26.1±18.4 years; range, 1 month to 65 years). Two patients (4%) had combined heart/liver transplantation; 1 (2%) had heart/kidney transplantation. Six patients (13%) had no previous cardiac operation; the remaining 39 patients had a mean of 3 (range, 1-8) previous cardiac operations. Patient survival (95% CI) at 1, 5, and 10 years was 89% (80%-98%), 89% (80%-98%), and 72% (56%-87%), respectively, while graft survival at 1, 5, and 10 years was 89% (80%-98%), 89% (80%-98%), and 61% (44%-78%), respectively. During the same era, the International Society for Heart & Lung Transplantation reported that survival in patients undergoing transplant for non-congenital diagnoses was 85%, 72%, and 56%, respectively. Over a mean follow-up of 8.7±6.2 years, rejection requiring treatment was documented in 35 patients (78%). Eleven patients (24%) have been diagnosed with neoplasia (8 skin, 1 blood, 1 lymph, and 1 other), and 3 patients (7%) have required retransplantation. Four patients (9%) have developed significant coronary vasculopathy; 1 successfully underwent retransplantation, and 3 died 6, 8, and 14 years after transplantation. With appropriate patient selection and posttransplant monitoring, survival has improved for patients with complex end-stage CHD. Multiorgan transplantation is an option for selected patients with CHD. OBJECTIVETo report our single-center experience with patients who had cardiac and multiorgan transplantation for end-stage congenital heart disease (CHD).PATIENTS AND METHODSWe reviewed records for all patients with CHD who had undergone heart transplantation at Mayo Clinic, Rochester, Minnesota, from November 1, 1990, through June 30, 2012. Patients with cardiomyopathy were excluded, unless CHD was present.RESULTSOverall, 45 patients had cardiac transplantation for end-stage CHD (mean age, 26.1±18.4 years; range, 1 month to 65 years). Two patients (4%) had combined heart/liver transplantation; 1 (2%) had heart/kidney transplantation. Six patients (13%) had no previous cardiac operation; the remaining 39 patients had a mean of 3 (range, 1-8) previous cardiac operations. Patient survival (95% CI) at 1, 5, and 10 years was 89% (80%-98%), 89% (80%-98%), and 72% (56%-87%), respectively, while graft survival at 1, 5, and 10 years was 89% (80%-98%), 89% (80%-98%), and 61% (44%-78%), respectively. During the same era, the International Society for Heart & Lung Transplantation reported that survival in patients undergoing transplant for non-congenital diagnoses was 85%, 72%, and 56%, respectively. Over a mean follow-up of 8.7±6.2 years, rejection requiring treatment was documented in 35 patients (78%). Eleven patients (24%) have been diagnosed with neoplasia (8 skin, 1 blood, 1 lymph, and 1 other), and 3 patients (7%) have required retransplantation. Four patients (9%) have developed significant coronary vasculopathy; 1 successfully underwent retransplantation, and 3 died 6, 8, and 14 years after transplantation.CONCLUSIONWith appropriate patient selection and posttransplant monitoring, survival has improved for patients with complex end-stage CHD. Multiorgan transplantation is an option for selected patients with CHD. |
Audience | Academic |
Author | O’Leary, Patrick W., MD Dearani, Joseph A., MD Burkhart, Harold M., MD Edwards, Brooks S., MD Daly, Richard C., MD Dahl, Sonja H., RN, CNP Johnson, Jonathan N., MD Robinson, Jeffrey A., MD Driscoll, David J., MD |
Author_xml | – sequence: 1 fullname: Robinson, Jeffrey A., MD – sequence: 2 fullname: Driscoll, David J., MD – sequence: 3 fullname: O’Leary, Patrick W., MD – sequence: 4 fullname: Burkhart, Harold M., MD – sequence: 5 fullname: Dearani, Joseph A., MD – sequence: 6 fullname: Daly, Richard C., MD – sequence: 7 fullname: Edwards, Brooks S., MD – sequence: 8 fullname: Dahl, Sonja H., RN, CNP – sequence: 9 fullname: Johnson, Jonathan N., MD |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24684872$$D View this record in MEDLINE/PubMed |
BookMark | eNqFklFrFDEQxxep2Gv1G4gsCNIHd02y2ezmRShna4UWH1qfw1wyu5dzLzmTXeG-vVmuar0XCSQw_P4zk_nPWXbivMMse01JSQkVHzblFvZe70pGaFVSWhIqn2ULKjkr6pqLk2xBCKsLQaU4zc5i3BBCGin5i-yUcdHytmGL7G4JwVjQOTiT303DaH3oweUPAVzcDeBGSCGXdz7kV84U9yP0mC-969HZEYb8BiGM-ScbESK-zJ53MER89fieZ9-urx6WN8Xt189flpe3ha5rNhYciNRCs6bSmrRGgJSMGEEaXaOQrDJgNLSsJjVtAQTvoGpEhYRT1MaIVXWeXRzy7oL_MWEc1dZGjUPqF_0UFa0pY6ymsk3o2yN046fgUnczxVPhljeJKg9UDwMq6zo_BtDpGNxanQbf2RS_rBrKWl5zmQTvngjWCMO4jn6Y5mHFf8H3T8DVFK3DmK5o-_UYe5jiEc4PuA4-xoCd2gW7hbBXlKjZd7VRB9_V7LuiVCXfk-zN4y-n1RbNH9FvoxPw8QBgsuWnxaCitug0GhtQj8p4-78Kxwn0YJ3VMHzHPca_Q1WRKaLu592bV49WhFIqRPULyFvUHw |
CODEN | MACPAJ |
CitedBy_id | crossref_primary_10_1007_s00398_016_0134_x crossref_primary_10_1161_JAHA_119_014088 crossref_primary_10_1016_j_athoracsur_2015_03_001 crossref_primary_10_1016_j_tcm_2016_04_004 crossref_primary_10_1007_s11936_015_0376_z crossref_primary_10_1016_j_jacc_2019_09_004 crossref_primary_10_1586_14779072_2016_1133294 crossref_primary_10_1007_s11936_015_0412_z crossref_primary_10_1016_j_cjca_2019_12_025 crossref_primary_10_1161_CIR_0000000000000353 crossref_primary_10_1556_OH_2015_30072 |
Cites_doi | 10.1016/j.jtcvs.2010.03.036 10.4065/73.10.923 10.1016/j.transproceed.2012.01.085 10.1016/j.athoracsur.2012.02.052 10.1002/hep.25692 10.1093/ejcts/ezs350 10.2174/157340311797484240 10.1016/j.hfc.2012.04.002 10.1161/CIRCULATIONAHA.111.040360 10.1016/j.healun.2012.08.001 |
ContentType | Journal Article |
Copyright | Mayo Foundation for Medical Education and Research 2014 Mayo Foundation for Medical Education and Research Copyright © 2014 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved. COPYRIGHT 2014 Elsevier, Inc. Copyright Mayo Foundation for Medical Education and Research Apr 2014 |
Copyright_xml | – notice: Mayo Foundation for Medical Education and Research – notice: 2014 Mayo Foundation for Medical Education and Research – notice: Copyright © 2014 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved. – notice: COPYRIGHT 2014 Elsevier, Inc. – notice: Copyright Mayo Foundation for Medical Education and Research Apr 2014 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 4U- 7RV 7T5 7X7 7XB 88E 88I 8AF 8C1 8FI 8FJ 8FK ABUWG AFKRA AZQEC BEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9- K9. KB0 M0R M0S M1P M2P NAPCQ PQEST PQQKQ PQUKI PRINS Q9U S0X 7X8 |
DOI | 10.1016/j.mayocp.2013.11.019 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) University Readers ProQuest Nursing and Allied Health Journals Immunology Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central ProQuest Central Essentials eLibrary ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Consumer Health Database Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Science Database Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic SIRS Editorial MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef University Readers ProQuest Central Student ProQuest Central Essentials SIRS Editorial elibrary ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Science Journals (Alumni Edition) ProQuest Central Basic ProQuest Science Journals ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | University Readers MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1942-5546 |
EndPage | 483 |
ExternalDocumentID | 3272492341 A371284549 10_1016_j_mayocp_2013_11_019 24684872 S0025619613011166 1_s2_0_S0025619613011166 |
Genre | Journal Article |
GeographicLocations | Minnesota |
GeographicLocations_xml | – name: Minnesota |
GroupedDBID | - 08P 08R 0R 1- 18M 1P 29M 2WC 354 36B 3O- 3V. 4.4 457 53G 55 5GY 5RE 7RV 7X7 88E 88I 8AF 8C1 8F7 8FI 8FJ 96U AAEDT AAIAV AAKAS AALRI AALRV AAQQT AAQXK AAWTL AAXUO AAYEP AAYOK ABFLS ABLJU ABMAC ABPTK ABQIS ABUWG ABWYI ACGFO ACGOD ACPRK ADACO ADBBV ADFRT ADZCM AENEX AERZD AEVXI AFAZI AFCTW AFFNX AFKRA AFRHN AFTJW AGNAY AHMBA AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ ASPBG AVWKF AZFZN AZQEC BAAKF BAWUL BBAFP BCR BCU BEC BENPR BES BKEYQ BKNYI BKOMP BLC BPHCQ BVXVI DIK DU5 DWQXO E3Z EBS EJD EX3 F8P F9R FAC FAS FDB FEDTE FGOYB FJW FO FYUFA GJ GNUQQ GX1 H13 HCIFZ HVGLF HYE HZ IAO ICW IEA IHR IHW INH INR IOF IPNFZ ITC J5H K K9- L7B M0R M1P M2P M2Q M41 N4W N95 NAPCQ O9- OD. OHT OK1 OO OVD P2P PCD PEA PQEST PQQKQ PQUKI PRINS PROAC PSQYO R2- RIG ROL RPM RVF RWL RXW S0X SEL SJFOW TAE TAF TEORI TJF TR2 U5U UNMZH VVN W8F WH7 WOW X7M XH2 XI7 YFH YOC Z5R ZA5 ZGI ZXP --- --K .1- .55 .FO .GJ 0R~ 1CY 1P~ AAEDW ABCQX ABJNI ADMUD AHPSJ CCPQU HMCUK HZ~ OO~ UKHRP AFJKZ ALIPV CGR CUY CVF ECM EIF NPM AAYXX CITATION 4U- 7T5 7XB 8FK H94 K9. Q9U 7X8 |
ID | FETCH-LOGICAL-c552t-4a09c6c273cc08d6a9920d607c5e6923dadca8250518aa64fa3763e041ecdd6b3 |
IEDL.DBID | 7X7 |
ISSN | 0025-6196 |
IngestDate | Fri Aug 16 09:11:08 EDT 2024 Fri Sep 13 07:53:55 EDT 2024 Fri Feb 02 04:27:34 EST 2024 Tue Aug 20 22:14:04 EDT 2024 Thu Oct 26 20:16:18 EDT 2023 Thu Sep 26 17:19:14 EDT 2024 Sat Sep 28 08:02:55 EDT 2024 Fri Feb 23 02:33:19 EST 2024 Thu Aug 18 17:13:03 EDT 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | congenital heart disease UNOS United Network for Organ Sharing CHD |
Language | English |
License | Copyright © 2014 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c552t-4a09c6c273cc08d6a9920d607c5e6923dadca8250518aa64fa3763e041ecdd6b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 24684872 |
PQID | 1514920847 |
PQPubID | 48850 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1512225198 proquest_journals_1514920847 gale_infotracacademiconefile_A371284549 gale_healthsolutions_A371284549 gale_businessinsightsgauss_A371284549 crossref_primary_10_1016_j_mayocp_2013_11_019 pubmed_primary_24684872 elsevier_sciencedirect_doi_10_1016_j_mayocp_2013_11_019 elsevier_clinicalkeyesjournals_1_s2_0_S0025619613011166 |
PublicationCentury | 2000 |
PublicationDate | 2014-04-01 |
PublicationDateYYYYMMDD | 2014-04-01 |
PublicationDate_xml | – month: 04 year: 2014 text: 2014-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Rochester |
PublicationTitle | Mayo Clinic proceedings |
PublicationTitleAlternate | Mayo Clin Proc |
PublicationYear | 2014 |
Publisher | Elsevier Inc Elsevier, Inc Elsevier Limited |
Publisher_xml | – name: Elsevier Inc – name: Elsevier, Inc – name: Elsevier Limited |
References | Speziali, Driscoll, Danielson (bib5) 1998; 73 Seddio, Gorislavets, Iacovoni (bib2) 2013; 43 Voeller, Epstein, Guthrie (bib3) 2012; 94 Siân Pincott, Burch (bib8) 2011; 7 Asrani, Asrani, Freese (bib7) 2012; 56 Luo, Chou, Chen (bib9) 2012; 44 Gupta, Tonelli, Krasuski (bib6) 2012; 8 Topilsky, Hasin, Raichlin (bib10) 2012; 125 Karamlou, Hirsch, Welke (bib4) 2010; 140 Kirk, Dipchand, Edwards (bib1) 2012; 31 Asrani (10.1016/j.mayocp.2013.11.019_bib7) 2012; 56 Speziali (10.1016/j.mayocp.2013.11.019_bib5) 1998; 73 Siân Pincott (10.1016/j.mayocp.2013.11.019_bib8) 2011; 7 Voeller (10.1016/j.mayocp.2013.11.019_bib3) 2012; 94 Luo (10.1016/j.mayocp.2013.11.019_bib9) 2012; 44 Karamlou (10.1016/j.mayocp.2013.11.019_bib4) 2010; 140 Kirk (10.1016/j.mayocp.2013.11.019_bib1) 2012; 31 Seddio (10.1016/j.mayocp.2013.11.019_bib2) 2013; 43 Gupta (10.1016/j.mayocp.2013.11.019_bib6) 2012; 8 Topilsky (10.1016/j.mayocp.2013.11.019_bib10) 2012; 125 |
References_xml | – volume: 31 start-page: 1065 year: 2012 end-page: 1072 ident: bib1 article-title: The Registry of the International Society for Heart and Lung Transplantation: fifteenth pediatric heart transplantation report–2012 publication-title: J Heart Lung Transplant contributor: fullname: Edwards – volume: 140 start-page: 161 year: 2010 end-page: 168 ident: bib4 article-title: A United Network for Organ Sharing analysis of heart transplantation in adults with congenital heart disease: outcomes and factors associated with mortality and retransplantation publication-title: J Thorac Cardiovasc Surg contributor: fullname: Welke – volume: 56 start-page: 1160 year: 2012 end-page: 1169 ident: bib7 article-title: Congenital heart disease and the liver publication-title: Hepatology contributor: fullname: Freese – volume: 125 start-page: 708 year: 2012 end-page: 720 ident: bib10 article-title: Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation publication-title: Circulation contributor: fullname: Raichlin – volume: 44 start-page: 913 year: 2012 end-page: 914 ident: bib9 article-title: Heart retransplantation for pediatric primary allograft failure publication-title: Transplant Proc contributor: fullname: Chen – volume: 73 start-page: 923 year: 1998 end-page: 928 ident: bib5 article-title: Cardiac transplantation for end-stage congenital heart defects: the Mayo Clinic experience. Mayo Cardiothoracic Transplant Team publication-title: Mayo Clin Proc contributor: fullname: Danielson – volume: 43 start-page: 605 year: 2013 end-page: 611 ident: bib2 article-title: Is heart transplantation for complex congenital heart disease a good option? A 25-year single centre experience publication-title: Eur J Cardiothorac Surg contributor: fullname: Iacovoni – volume: 94 start-page: 807 year: 2012 end-page: 815 ident: bib3 article-title: Trends in the indications and survival in pediatric heart transplants: a 24-year single-center experience in 307 patients publication-title: Ann Thorac Surg contributor: fullname: Guthrie – volume: 7 start-page: 51 year: 2011 end-page: 58 ident: bib8 article-title: Indications for heart transplantation in congenital heart disease publication-title: Curr Cardiol Rev contributor: fullname: Burch – volume: 8 start-page: 427 year: 2012 end-page: 445 ident: bib6 article-title: Congenital heart disease and pulmonary hypertension publication-title: Heart Fail Clin contributor: fullname: Krasuski – volume: 140 start-page: 161 issue: 1 year: 2010 ident: 10.1016/j.mayocp.2013.11.019_bib4 article-title: A United Network for Organ Sharing analysis of heart transplantation in adults with congenital heart disease: outcomes and factors associated with mortality and retransplantation publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2010.03.036 contributor: fullname: Karamlou – volume: 73 start-page: 923 issue: 10 year: 1998 ident: 10.1016/j.mayocp.2013.11.019_bib5 article-title: Cardiac transplantation for end-stage congenital heart defects: the Mayo Clinic experience. Mayo Cardiothoracic Transplant Team publication-title: Mayo Clin Proc doi: 10.4065/73.10.923 contributor: fullname: Speziali – volume: 44 start-page: 913 issue: 4 year: 2012 ident: 10.1016/j.mayocp.2013.11.019_bib9 article-title: Heart retransplantation for pediatric primary allograft failure publication-title: Transplant Proc doi: 10.1016/j.transproceed.2012.01.085 contributor: fullname: Luo – volume: 94 start-page: 807 issue: 3 year: 2012 ident: 10.1016/j.mayocp.2013.11.019_bib3 article-title: Trends in the indications and survival in pediatric heart transplants: a 24-year single-center experience in 307 patients publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2012.02.052 contributor: fullname: Voeller – volume: 56 start-page: 1160 issue: 3 year: 2012 ident: 10.1016/j.mayocp.2013.11.019_bib7 article-title: Congenital heart disease and the liver publication-title: Hepatology doi: 10.1002/hep.25692 contributor: fullname: Asrani – volume: 43 start-page: 605 issue: 3 year: 2013 ident: 10.1016/j.mayocp.2013.11.019_bib2 article-title: Is heart transplantation for complex congenital heart disease a good option? A 25-year single centre experience publication-title: Eur J Cardiothorac Surg doi: 10.1093/ejcts/ezs350 contributor: fullname: Seddio – volume: 7 start-page: 51 issue: 2 year: 2011 ident: 10.1016/j.mayocp.2013.11.019_bib8 article-title: Indications for heart transplantation in congenital heart disease publication-title: Curr Cardiol Rev doi: 10.2174/157340311797484240 contributor: fullname: Siân Pincott – volume: 8 start-page: 427 issue: 3 year: 2012 ident: 10.1016/j.mayocp.2013.11.019_bib6 article-title: Congenital heart disease and pulmonary hypertension publication-title: Heart Fail Clin doi: 10.1016/j.hfc.2012.04.002 contributor: fullname: Gupta – volume: 125 start-page: 708 issue: 5 year: 2012 ident: 10.1016/j.mayocp.2013.11.019_bib10 article-title: Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.111.040360 contributor: fullname: Topilsky – volume: 31 start-page: 1065 issue: 10 year: 2012 ident: 10.1016/j.mayocp.2013.11.019_bib1 article-title: The Registry of the International Society for Heart and Lung Transplantation: fifteenth pediatric heart transplantation report–2012 publication-title: J Heart Lung Transplant doi: 10.1016/j.healun.2012.08.001 contributor: fullname: Kirk |
SSID | ssj0007994 |
Score | 2.2167394 |
Snippet | Abstract Objective To report our single-center experience with patients who had cardiac and multiorgan transplantation for end-stage congenital heart disease... To report our single-center experience with patients who had cardiac and multiorgan transplantation for end-stage congenital heart disease (CHD). We reviewed... To report our single-center experience with patients who had cardiac and multiorgan transplantation for end-stage congenital heart disease (CHD). We reviewed... OBJECTIVETo report our single-center experience with patients who had cardiac and multiorgan transplantation for end-stage congenital heart disease... |
SourceID | proquest gale crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 478 |
SubjectTerms | Academic Medical Centers Adolescent Adult Child Child, Preschool Cohort Studies Confidence Intervals Congenital heart disease Critical Illness Female Follow-Up Studies Graft Rejection Graft Survival Heart Heart Defects, Congenital - diagnosis Heart Defects, Congenital - mortality Heart Defects, Congenital - surgery Heart Failure - diagnosis Heart Failure - mortality Heart Failure - surgery Heart Transplantation - methods Heart Transplantation - mortality Humans Infant Internal Medicine Kidney Transplantation - methods Kidney Transplantation - mortality Liver Transplantation - methods Liver Transplantation - mortality Male Minnesota Retrospective Studies Risk Assessment Risk factors Survival Rate Transplantation Treatment Outcome Young Adult |
Title | Cardiac and Multiorgan Transplantation for End-Stage Congenital Heart Disease |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0025619613011166 https://dx.doi.org/10.1016/j.mayocp.2013.11.019 https://www.ncbi.nlm.nih.gov/pubmed/24684872 https://www.proquest.com/docview/1514920847/abstract/ https://search.proquest.com/docview/1512225198 |
Volume | 89 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELZKKyEuFW8CpRgJxMlsnHid-ITKstUKaSsEVNqb5VcrVTQpJHvg3zPjxIFWCC65ZJIo4_E339ieGUJecXtWKKsEs0IIJlTJWS1Kw1QQtvRYf1xgcvL6RK5OxcfNfLNDVikXBo9VJkyMQO1bh2vkM_BMQhU5gOnMWFwFcP3s3dV3hv2jcJ91bKZxi-xxkEKLrzZT6JVXSonUvBVCBpmS6OJJr0vzs3VYu5KXb7GiJ1bd-buTuonaN7ho9EnHd8n-SCbp0TD698hOaO6T2-txu_wBWS_i-DtqGk9jqm1s4kSHiubfzJB21FAgrnTZeAbM8zzQRYv5VthMhK5gHvT0w7CJ85CcHi-_LlZs7J_A3Hxe9EyYXDnpgKA4l9deGgUK9DKv3DxIIHbeeGdq5EC8NkaKM4NoE3LBg_Ne2vIR2W3aJjwhFOJYUXkeuK1KoFylkcbaXAivsFJ5aTLCksL01VAmQ6fzYxd6ULBGBUPEoUHBGamSVnVKAQXQCt04gzrNdVfoXH-JpAxGjCMScSn_fHIkCYPz1-AD_vPN1zh8euzuCZcO1z-6c7PtOn1UVuiqIVzOyIsoNySiTghwTeJNlEAMQEs0YyoD6AqraV2TPEi2on__2mTKGXk53YZpjXs1pgntNspgJM5VnZHHg41Nii2ErCHOLJ7---XPyB34-_GY0QHZ7X9sw3NgUL09jJMDrvWCH5K998uTT59_ATbcGUA |
link.rule.ids | 315,786,790,12083,12250,21416,27957,27958,31754,31755,33301,33302,33779,33780,43345,43614,43840,74102,74371,74659 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELagSNAL4t1AoUYCcTKNY68Tn1C1tFqg2wut1Jvl2G4lBElpsgf-PTO2s6UVgsteMrvRfvbMfGPPg5A3vD2rdKsla6WUTGrBWSOFZTrIVnjsPy6xOHl5pBYn8vPp7DQfuA05rXKyidFQ-97hGfkueCapqxKM6YeLnwynRuHtah6hcZvckQIcDVaKz69SPGqt5TSyFQIFNZXOxfyuH_ZX77BjJRfvsY8n9tr5u2u6aatvMNDoiQ4ekPuZQtK9tOYPya3QPSJ3l_mS_DFZzuOqO2o7T2OBbRzdRFMf8-82FRt1FOgq3e88A755Hui8xyorHCFCF7D7R_oxXd08IScH-8fzBctTE5ibzaqRSVtqpxzQEufKxiurATavytrNggI65613tkHmwxtrlTyzaGNCKXlw3qtWPCUbXd-FLUIhepW154G3tQCiJayybVtK6TX2Jxe2IGwCzFyk5hhmyhr7ZhLABgGGOMMAwAWpJ1TNVPgJpioMWW8Gw81QmdJ8jVQMVoyj_eFK_fnNTA2Syzdg-f_zzre4fCbP9ISPAU89hnO7GgazJ2p00BAkF2QnyqXy07XeX5N4FyVQ88dL62wuYACssIfWNcntaa-Yq7-23sAFeb1-DMqMNzS2C_0qymD8zXVTkGdpj62BraRqILqsnv_7x3fIvcXx8tAcfjr68oJsAhI50WibbIyXq_ASONTYvoqK8htsLxXX |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELaglSouiHdTCjUSiJNpnDhOfEJlu6vlsasKqNSb5djeSgiStske-PfMOM5CKwSXvWR2o53MfPNNPA9CXvJ6lalaCVYLIZhQOWeVyA1TXtS5w_njApuTF0s5PxUfzoqzWP_UxbLKERMDULvW4jvyQ4hMQmUpgOnhKpZFnBzP3l5cMtwghSetcZ3GbbJdClmAhW-_my5PPm9wuVRKjAtcIW2QYyNdqPb6YX62FudX8vwNTvXEyTt_D1Q3kfsGHw1xaXaP3I2Ekh4NFnCf3PLNA7KziEfmD8liEmzAUtM4GtptwyInOkw1_26G1qOGAnml08YxYJ_nnk5a7LnChSJ0Dr7Q0-PhIOcROZ1Nv07mLO5QYLYosp4JkyorLZAUa9PKSaNAiU6mpS28BHLnjLOmQh7EK2OkWBlEHJ8K7q1zss4fk62mbfwuoZDLitJxz-syB9qVG2nqOhXCKZxWnpuEsFFh-mIYlaHHGrJvelCwRgVD1qFBwQkpR63qsQ0UgMt30Ys6zXWX6VR_CcQMnhhHNOJS_vnNSBQGAqAhDvznnq_w8em44RM-OnwH0p2bddfpo7zEcA0pc0IOgtzQjLpBgWsSr4ME4kB_ZayJ7QygK5yodU1yf7QV_fuvbcw5IS82l8G18bzGNL5dBxnMxrmqEvJksLGNYjMhK8g1s71___gB2QEv0Z_eLz8-JXdAEbHqaJ9s9Vdr_wwIVV8_j57yC-HdG68 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cardiac+and+multiorgan+transplantation+for+end-stage+congenital+heart+disease&rft.jtitle=Mayo+Clinic+proceedings&rft.au=Robinson%2C+Jeffrey+A&rft.au=Driscoll%2C+David+J&rft.au=O%27Leary%2C+Patrick+W&rft.au=Burkhart%2C+Harold+M&rft.date=2014-04-01&rft.pub=Elsevier%2C+Inc&rft.issn=0025-6196&rft.eissn=1942-5546&rft.volume=89&rft.issue=4&rft.spage=478&rft_id=info:doi/10.1016%2Fj.mayocp.2013.11.019&rft.externalDocID=A371284549 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00256196%2FS0025619613X00163%2Fcov150h.gif |